stars 1 stars 2 stars 3

SermesCRO is a full CRO (Contract Research Organization), providing quality clinical research services for 27 years. We partner you through the hole drug development cycle: from early phases, to post-marketing studies. Based on a strong scientific, therapeutical and regulatory expertise, we will keep your study on track. It will be delivered within time, quality and profitability targets. We provide a comprehensive range of services to fulfill any global CT needs: clinical operations, start up, pharmacovigilance, legal representation, regulatory advice, data management and qualified outsourced staff. We are an experienced partner in EMA’s new Clinial Trial Information System (CTIS), as part of it’s working group since 2017. Our Advanced Therapies Unit provides counseling on regulations and regulatory requirements from the outset and throughout the research Project. Our Artificial Intelligence and Big Data Unit provides unique clinical research data, expert analysis and innovative business intelligent solutions.

Sermes CRO Questions

The Sermes CRO annual revenue was $65.9 million in 2026.

Luis Angel Varela Serrano is the CEO - SERMES CRO of Sermes CRO.

126 people are employed at Sermes CRO.

Sermes CRO is based in Madrid, Madrid.

The NAICS codes for Sermes CRO are [5417, 541713, 54, 54171, 541].

The SIC codes for Sermes CRO are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users